Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| UNITED THERAPEUTICS CorpUTHR · Entity 664 | Director | July 22, 2026 | July 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
UNITED THERAPEUTICS Corp
Report date July 22, 2026 · Filed July 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $527.07 · Expires 2033-07-22 | Direct | 2,380 |
Reported balance
After 2026-07-22 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-22 · Grant · Acquired 2,380 · Balance 2,380 F1: Annual non-employee director award. F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. |
| Common StockSEC Table I · non-derivative | Direct | 2,410 |
Reported balance
Holding disclosure · report date 2026-07-22 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,410 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual non-employee director award.
F2: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2026 Filed Jul 23, 2026 20:37 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Option · Derivative | 2,380 | $0.00 Strike: $527.07 | $0.00 |
DisclosureSEC source: 0001231427-26-000004 · primarydocument.xml · derivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,380 Underlying: Common Stock · 2,380 shares Expires 2033-07-22 F1 · shares: Annual non-employee director award. F2 · derivative.exercise_date: Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:35 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001231427-26-000003 · primarydocument.xml · derivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · kind: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 09, 2026 Filed Jul 13, 2026 20:35 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001231427-26-000003 · primarydocument.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| April 24, 2026 Filed Apr 24, 2026 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 2,910 | $0.00 Strike: $101.80 | $0.00 |
DisclosureSEC source: 0001231427-26-000002 · primarydocument.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,910 shares Expires 2026-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025. Read SEC document |
| April 24, 2026 Filed Apr 24, 2026 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,910 | $569.00 | $1,655,790.00 |
DisclosureSEC source: 0001231427-26-000002 · primarydocument.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,490 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025. Read SEC document |
| April 24, 2026 Filed Apr 24, 2026 20:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,910 | $101.80 | $296,238.00 |
DisclosureSEC source: 0001231427-26-000002 · primarydocument.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025. Read SEC document |
| April 17, 2026 Filed Apr 17, 2026 20:57 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $101.80 | $0.00 |
DisclosureSEC source: 0001231427-26-000001 · primarydocument.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,910 Underlying: Common Stock · 1,000 shares Expires 2026-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025. Read SEC document |
| April 17, 2026 Filed Apr 17, 2026 20:57 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $578.88 | $578,880.00 |
DisclosureSEC source: 0001231427-26-000001 · primarydocument.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,490 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025. Read SEC document |
| April 17, 2026 Filed Apr 17, 2026 20:57 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,000 | $101.80 | $101,800.00 |
DisclosureSEC source: 0001231427-26-000001 · primarydocument.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on December 18, 2025. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $101.80 | $0.00 |
DisclosureSEC source: 0001231427-25-000004 · primarydocument.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,910 Underlying: Common Stock · 1,000 shares Expires 2026-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,000 | $495.95 | $495,953.90 |
DisclosureSEC source: 0001231427-25-000004 · primarydocument.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,490 F1 · price: This transaction was executed in multiple trades at prices ranging from $495.64 to $496.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,000 | $101.80 | $101,800.00 |
DisclosureSEC source: 0001231427-25-000004 · primarydocument.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:27 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005530 · primarydocument.xml · derivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 590 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2025 Filed Jul 28, 2025 10:27 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 590 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005530 · primarydocument.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,490 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:27 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-005530 · primarydocument.xml · derivative · entry 5 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 650 Underlying: Common Stock · 650 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F4 · shares: Annual non-employee director award. F1 · price: Shares received upon vesting of restricted stock units on July 25, 2025. Restricted stock units converted on a one-for-one basis into shares of common stock. F3 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 24, 2025 Filed Jul 28, 2025 10:27 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 1,830 | $0.00 Strike: $306.41 | $0.00 |
DisclosureSEC source: 0001562180-25-005530 · primarydocument.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,830 Underlying: Common Stock · 1,830 shares Expires 2035-07-24 F4 · shares: Annual non-employee director award. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 22:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001562180-25-002636 · primarydocument.xml · derivative · entry 10 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 22:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 100 | $313.77 | $31,377.00 |
DisclosureSEC source: 0001562180-25-002636 · primarydocument.xml · nonDerivative · entry 8 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 900 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 22:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,299 | $313.14 | $406,768.86 |
DisclosureSEC source: 0001562180-25-002636 · primarydocument.xml · nonDerivative · entry 7 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,000 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F7 · price: This transaction was executed in multiple trades at prices ranging from $312.735 to $313.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 22:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 736 | $312.22 | $229,791.79 |
DisclosureSEC source: 0001562180-25-002636 · primarydocument.xml · nonDerivative · entry 6 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,299 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F6 · price: This transaction was executed in multiple trades at prices ranging from $311.68 to $312.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 22:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 457 | $310.80 | $142,035.10 |
DisclosureSEC source: 0001562180-25-002636 · primarydocument.xml · nonDerivative · entry 5 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,035 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F5 · price: This transaction was executed in multiple trades at prices ranging from $310.48 to $310.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 22:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 328 | $309.73 | $101,590.85 |
DisclosureSEC source: 0001562180-25-002636 · primarydocument.xml · nonDerivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,492 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $309.48 to $310.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 22:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,780 | $308.82 | $549,701.02 |
DisclosureSEC source: 0001562180-25-002636 · primarydocument.xml · nonDerivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,820 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $308.44 to $309.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 22:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 300 | $307.73 | $92,319.96 |
DisclosureSEC source: 0001562180-25-002636 · primarydocument.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,600 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $307.32 to $308.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 19, 2025 Filed Mar 20, 2025 22:11 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $175.43 | $877,150.00 |
DisclosureSEC source: 0001562180-25-002636 · primarydocument.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001562180-25-000328 · primarydocument.xml · derivative · entry 9 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 109 | $363.86 | $39,661.05 |
DisclosureSEC source: 0001562180-25-000328 · primarydocument.xml · nonDerivative · entry 7 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 900 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F7 · price: This transaction was executed in multiple trades at prices ranging from $363.80 to $364.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,092 | $362.95 | $396,346.75 |
DisclosureSEC source: 0001562180-25-000328 · primarydocument.xml · nonDerivative · entry 6 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,009 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F6 · price: This transaction was executed in multiple trades at prices ranging from $362.49 to $363.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,930 | $362.03 | $698,724.46 |
DisclosureSEC source: 0001562180-25-000328 · primarydocument.xml · nonDerivative · entry 5 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,101 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F5 · price: This transaction was executed in multiple trades at prices ranging from $361.485 to $362.47. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 969 | $361.04 | $349,850.47 |
DisclosureSEC source: 0001562180-25-000328 · primarydocument.xml · nonDerivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,031 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F4 · price: This transaction was executed in multiple trades at prices ranging from $360.395 to $361.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 600 | $359.82 | $215,892.66 |
DisclosureSEC source: 0001562180-25-000328 · primarydocument.xml · nonDerivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,000 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F3 · price: This transaction was executed in multiple trades at prices ranging from $359.12 to $360.095. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 300 | $358.65 | $107,596.47 |
DisclosureSEC source: 0001562180-25-000328 · primarydocument.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,600 F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. F2 · price: This transaction was executed in multiple trades at prices ranging from $358.11 to $358.895. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. the price reported above reflects the weighted average sale price. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 21:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 5,000 | $175.43 | $877,150.00 |
DisclosureSEC source: 0001562180-25-000328 · primarydocument.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on August 27, 2024. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 4,300 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-24-022908 · form4-09052024_040901.xml · derivative · entry 7 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 4,300 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 4,300 | $353.36 | $1,519,433.81 |
DisclosureSEC source: 0001415889-24-022908 · form4-09052024_040901.xml · nonDerivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900 Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 4,300 | $175.43 | $754,349.00 |
DisclosureSEC source: 0001415889-24-022908 · form4-09052024_040901.xml · nonDerivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 700 | $0.00 Strike: $175.43 | $0.00 |
DisclosureSEC source: 0001415889-24-022908 · form4-09052024_040901.xml · derivative · entry 6 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,300 Underlying: Common Stock · 700 shares Expires 2025-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 700 | $360.31 | $252,213.57 |
DisclosureSEC source: 0001415889-24-022908 · form4-09052024_040901.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900 F1 · price: This transaction was executed in multiple trades at prices ranging from $360.17 to $360.635. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 700 | $175.43 | $122,801.00 |
DisclosureSEC source: 0001415889-24-022908 · form4-09052024_040901.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantRestricted Stock Unit · Derivative | 590 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-020167 · form4-07262024_040715.xml · derivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 590 Underlying: Common Stock · 590 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock. F1 · shares: Annual non-employee director award. F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date. F4 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 25, 2024 Filed Jul 26, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | GrantStock Options · Derivative | 1,440 | $0.00 Strike: $336.37 | $0.00 |
DisclosureSEC source: 0001415889-24-020167 · form4-07262024_040715.xml · derivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,440 Underlying: Common Stock · 1,440 shares Expires 2034-07-25 F1 · shares: Annual non-employee director award. F2 · derivative.exercise_date: These awards vest on the one-year anniversary of the grant date. Read SEC document |
| July 13, 2024 Filed Jul 15, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionRestricted Stock Unit · Derivative | 900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019551 · form4-07152024_040712.xml · derivative · entry 3 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · kind: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. F2 · derivative.expiration_date: Not applicable as restricted stock units do not have an expiration date. Read SEC document |
| July 13, 2024 Filed Jul 15, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019551 · form4-07152024_040712.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. F1 · price: Shares received upon vesting of restricted stock units on July 13, 2024. Restricted stock units converted on a one-for-one basis into shares of common stock. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 2,000 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001415889-24-017414 · form4-06182024_040604.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 2,000 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 2,000 | $295.50 | $591,000.00 |
DisclosureSEC source: 0001415889-24-017414 · form4-06182024_040604.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 2,000 | $76.36 | $152,720.00 |
DisclosureSEC source: 0001415889-24-017414 · form4-06182024_040604.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionStock Options · Derivative | 1,310 | $0.00 Strike: $76.36 | $0.00 |
DisclosureSEC source: 0001415889-24-013238 · form4-05152024_040522.xml · derivative · entry 4 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 1,310 shares Expires 2029-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,310 | $264.35 | $346,298.50 |
DisclosureSEC source: 0001415889-24-013238 · form4-05152024_040522.xml · nonDerivative · entry 2 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:30 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | Exercise / conversionCommon Stock | 1,310 | $76.26 | $99,900.60 |
DisclosureSEC source: 0001415889-24-013238 · form4-05152024_040522.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Reflects an adjustment to total holdings to exclude four shares incorrectly included in prior reports due to administrative error. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:31 UTC | UNITED THERAPEUTICS Corp UTHR · Entity 664 | SaleCommon Stock | 1,680 | $224.00 | $376,320.00 |
DisclosureSEC source: 0001415889-24-005245 · form4-02262024_040226.xml · nonDerivative · entry 1 PATUSKY CHRISTOPHER · CIK 0001231427 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.